Elekta AB Total Long Term Liabilities 2013-2024 | EKTAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Elekta AB total long term liabilities from 2013 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Elekta AB total long term liabilities from 2013 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.6B
Intuitive Surgical (ISRG)	$186.7B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.5B
Edwards Lifesciences (EW)	$38.8B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$26.9B
Waters (WAT)	$22.9B
SONOVA HOLDING (SONVY)	$22B
STERIS (STE)	$21.3B
Hologic (HOLX)	$18.4B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Sysmex ADR (SSMXY)	$12.4B
Globus Medical (GMED)	$11.1B
Teleflex (TFX)	$9.2B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.7B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.9B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Tandem Diabetes Care (TNDM)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.3B
Artivion (AORT)	$1.2B